$INSY The share price continues to incrementally i
Post# of 212
Getting through the next several months without a major drop in price will rest with the CEO/Senior Execs at Insys Therapeutics. So far they have done an exemplary job of keeping the company active and profitable. R&D continues and existing products continue to be marketed.
Holding on to my shares based upon the leadership capabilities of the
CEO/Senior Execs.